Nutritional status, breastfeeding, and evolution of Infants with acute viral bronchiolitis

Cristina T L Dornelles1, Jefferson P Piva, Paulo J C Marostica

  • 1Nutrition Departament, Hospital de Clínicas de Porto Alegre/RS, Rua: Ramiro Barcelos, 2350, 90035903-Porto Alegre-RS, Brazil. cleal@hcpa.ufrgs.br

Insights

Exclusive breastfeeding duration is linked to better outcomes for infants with acute viral bronchiolitis. Longer exclusive breastfeeding reduces hospital stay and oxygen use in infants with this common respiratory illness.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Nutrition

Background:

  • Acute viral bronchiolitis is a frequent respiratory infection in infants.
  • Nutritional status and breastfeeding practices may influence disease severity.
  • Understanding risk factors is crucial for managing infant respiratory illnesses.

Purpose of the Study:

  • To assess nutritional and breastfeeding status in infants with acute viral bronchiolitis.
  • To identify risk factors for unfavorable clinical outcomes in these infants.
  • To evaluate the relationship between feeding practices and disease severity.

Main Methods:

  • Prospective study of 175 infants up to six months old with acute viral bronchiolitis.
  • Viral diagnosis via immunofluorescence test and nutritional assessment using anthropometry.
  • Outcomes measured included oxygen use duration, hospital stay length, and unit type.

Main Results:

  • Nutritional status did not significantly impact the clinical course of acute viral bronchiolitis.
  • Exclusive breastfeeding duration was inversely related to oxygen use and hospital stay length.
  • Shorter exclusive breastfeeding correlated with higher care unit admission (pediatric ward or ICU).

Conclusions:

  • Longer duration of exclusive breastfeeding is associated with improved clinical outcomes in infants with acute viral bronchiolitis.
  • Nutritional status alone did not predict disease severity in this cohort.
  • Promoting exclusive breastfeeding may mitigate the severity and duration of illness in infants.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: